Medical/Pharmaceuticals
Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA
First entry to clinical trial of exosome for atopic dermatitis The first exosome-based therapeutics in US clinical trial among Korean companies SEOUL, South Korea, Nov. 7, 2022 /PRNewswire/ -- The US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based ther...
2022-11-07 07:00
3655
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study
Summary of Study Outcomes * ZIRCON Phase III study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met all of its primary and secondary endpoints * The study delivered co-primary endpoints of 86% sensitivity and 87% specificity and 93% posit...
2022-11-07 06:48
2711
Fosun Participates in the CIIE for the Fifth Consecutive Year with the Debut of Innovative Products in China
HONG KONG, Nov. 4, 2022 /PRNewswire/ -- The 5th China International Import Expo (hereinafter referred to as the "CIIE") will be held inShanghai from 5 November to 10 November. Fosun will participate in the CIIE for the fifth consecutive year with its overseas member companies and partners from th...
2022-11-04 14:43
4973
Roche introduces the navify brand for its digital health solutions at HLTH 2022
* Roche unifies its digital health portfolio under the navify brand, providing a range of next generation software solutions. * The navify portfolio uses digital solutions, analytics and data science to provide insights that address today's real-world challenges in health, enabling confident ...
2022-11-04 14:00
4932
NSW Health & Cicada Innovations celebrate Australia's biggest health startup training program with 1.1k participants in first year
SYDNEY, Nov. 4, 2022 /PRNewswire/ -- The NSW Health Commercialisation Training
Program
2022-11-04 11:35
3687
LUMC to Fund New Clinical Trial of Cynata's Cymerus™ MSCs in Kidney Transplantation
Key Highlights: * Cynata to collaborate with Leiden University Medical Center (LUMC) in the Netherlands, in a new clinical trial in patients who have received a kidney transplant * Trial to be funded by LUMC; Cynata will supply iPSC-derived Cymerus mesenchymal stem cells (MSCs) at its cost t...
2022-11-04 09:15
4196
Werfen to Acquire Immucor, Inc., Expanding its Presence in Specialized Diagnostics
* Werfen enters into an agreement to acquire Immucor, Inc., a privately held, US-based corporation, with a solid global presence in transfusion and transplant in vitro diagnostics * The transaction is expected to close during the first half of 2023 BARCELONA, Spain, Nov. 4, 2022 /PRNewswire/ ...
2022-11-04 03:24
4852
Aquavit Celebrates Judgment Imposing Permanent Ban On Counterfeiters
NEW YORK, Nov. 4, 2022 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") secured a long-awaited and much-deserved judgment against counterfeiters. After nearly four years of court proceedings, the Honorable Valerie E. Caproni ofthe United States District Court for the Southern District o...
2022-11-04 01:37
4303
Kira Pharmaceuticals Presents Complete Data from Phase 1 SYNERGY-1 Trial of KP104 at American Society for Nephrology Kidney Week 2022
Biomarker data demonstrates proof-of-concept for KP104's dual-targeting mechanism via dose-dependent inhibition of alternative and terminal pathways and supports intravenous and subcutaneous administration of KP104 in phase 2 studies CAMBRIDGE, Mass. and SUZHOU, JIANGSU, China, Nov. 3, 2022 /PRN...
2022-11-03 21:30
3851
Merck KGaA, Darmstadt, Germany and p-Chip Corporation Collaborate to Improve Trust and Transparency in Machine-to-Machine Driven Industrial Value Chains
CHICAGO, Nov. 3, 2022 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany, a leading science and technology company, and p-Chip Corporation, a company that is revolutionizing the tracking of physical products and materials with its breakthrough microtransponder technology, today announced the conclusi...
2022-11-03 19:00
5747
Malaysia Seeks Strategic Global Partnerships to Accelerate Its Growth Trajectory As A Preferred Healthcare Destination
Explore the potentials of Malaysia Healthcare at World Travel Market London 2022
LONDON, Nov. 3, 2022 /PRNewswire/ -- Malaysia Healthcare is strengthening its
global proposition for preventive healthcare via strategic partnerships at the
World Travel Market 2022 ("WTM") in London.
2022-11-03 18:16
2997
The Adecco Group: Q3 22 RESULTS
- AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange - Accelerated growth and market share momentum, robust profitability ZURICH, Nov. 3, 2022 /PRNewswire/ -- HIGHLIGHTS * Revenues +16% reported, +6% yoy organic TDA * Growth leadership in Adecco; relative revenue grow...
2022-11-03 15:12
3685
Announcement of the Effect of Ginseng and Red Ginseng for Memory Improvement and Suppression of Bone and Muscle Loss
* Effect of improving blood pressure in patients with high blood pressure and diabetes * Announced at the 13th International Symposium on Ginseng 2022 SEOUL, South Korea, Nov. 3, 2022 /PRNewswire/ -- Experts who have conducted scientific studies on the effect of ginseng gathered inSeoul from ...
2022-11-03 14:24
4213
Docquity digitized patient affordability programs in the Philippines, saving over US$1M for patients
More than 350 doctors have supported over 1,000 cancer patients to get improved and affordable care since the start of the pilot last year MANILA, Philippines, Nov. 3, 2022 /PRNewswire/ -- In support of the Philippine government's initiatives to promote universal healthcare, Docquity, Southeast ...
2022-11-03 13:08
4746
CCTV+: Lyrics of White Peony Root into the Air
BEIJING, Nov. 3, 2022 /PRNewswire/ -- Located in southeast China, Jiangxi is ringed on three sides by mountains, bordering rivers and lakes on the north. Mountains and hills undulate in the region, with large basins scattering in the middle. The complex and diverse terrain, is a cradle for a vari...
2022-11-03 12:48
4101
First SEA Genomic Data Digitisation Collaboration Formed to Improve Cancer Clinical Trial Access
SINGAPORE, Nov. 3, 2022 /PRNewswire/ -- Oncoshot has just announced one of its biggest collaborations to date with Icon Cancer Centre inSingapore, alongside Roche. Together the partners plan to facilitate more comprehensive genomic profiling data to increase access to more trial options for cance...
2022-11-03 11:51
3508
First in-human use of OncoRes Medical's cancer imaging system successful
Quantitative Micro-Elastography (QME) Imaging System published in peer reviewed Cancer Research PERTH, Australia, Nov. 3, 2022 /PRNewswire/ -- OncoRes Medical today announces positive data from the first in-cavity use of its Quantitative Micro-Elastography (QME) Imaging System. The study, titled...
2022-11-03 06:00
2570
Turn Biotechnologies Names 25-year Biotech Industry Veteran Richard Peterson Chief Financial Officer
Seasoned Executive has Successful Track Record Working with Global Investors to Raise Billions of Dollars MOUNTAIN VIEW, Calif., Nov. 2, 2022 /PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today annou...
2022-11-02 21:00
4035
Antengene Announces IND Approval for the Phase I STAMINA-001 Study to Evaluate ATG-037 (CD73 Inhibitor) for the Treatment of Locally Advanced or Metastatic Solid Tumors in China
- ATG-037, an inhouse asset developed by Antengene and with global rights, has been approved to enter clinical studies inAustralia and China, thus becoming the firstoral small molecule CD73 inhibitor entering the clinical-stage in China and the wider Asia Pacific region. ATG-037 IND in Austr...
2022-11-02 20:07
3718
Dr Amit Kakar joins MedGenome Board of Directors
* The company has also added Navjeewan Khosla from Novo Holdings as Board Observer. * The company had announced a $50 million Series D investment led by Novo Holdings inAugust 2022. BANGALORE, India, Nov. 2, 2022 /PRNewswire/ -- MedGenome is a leading provider of genomic solutions for populat...
2022-11-02 10:00
3032
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 274 media titles]
2026-10-09 13:21The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth
[Picked up by 263 media titles]
2026-10-05 13:24
Most Read
RoboParty Unveils RP1, a High-Performance Full-Stack Open-Source Humanoid Robot at IROS
2026-10-04 00:56
10600
Nuix Neo Generative AI Framework
2026-10-08 08:02
9072
Silicon Quantum Computing Named to Fast Company's 2026 Next Big Things in Tech List
2026-10-06 19:38
8074
